Market Overview

Jefferies & Company Reiterates Buy Rating, $53 PT for Cabot Corporation

Related CBT
Top 4 Mid-Cap Stocks In The Specialty Chemicals Industry With The Highest EPS Growth Forecast For Next 5 Years
Cabot Norit Activated Carbon Awarded Two New Contracts for Mercury Removal

In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating and $53.00 price target for Cabot Corporation (NYSE: CBT).

Jefferies & Company went on to say “Cabot has announced the acquisition of Norit, the leading producer of activated carbon, for $1.1bn, or 12x 2011 EBITDA. We estimate the deal should be $0.33 accretive in calendar 2014, including $0.28 in deal synergies. At a 5% ROIC in 2013, the deal is equivalent to conducting a buyback at $78/share under the same financing assumptions. We reiterate our Buy rating.”

Cabot Corporation closed yesterday at $36.51.

Latest Ratings for CBT

Mar 2015NeedhamDowngradesBuyHold
Feb 2015Deutsche BankMaintainsHold
Aug 2014JefferiesMaintainsBuy

View More Analyst Ratings for CBT
View the Latest Analyst Ratings

Posted-In: Jefferies & Company Inc.Analyst Color Reiteration Analyst Ratings


Related Articles (CBT)

Around the Web, We're Loving...

Get Benzinga's Newsletters